Rituximab maintenance therapy in diffuse large B-cell lymphoma: Is XY the most important variable?

Matthew A. Lunning; James O. Armitage

doi:10.3324/haematol.2015.129924

Rituximab maintenance therapy in diffuse large B-cell lymphoma: Is XY the most important variable?

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	853-855
Number of pages	3
Journal	Haematologica
Volume	100
Issue number	7
DOIs	https://doi.org/10.3324/haematol.2015.129924
State	Published - Jul 6 2015

ASJC Scopus subject areas

Hematology

Access to Document

10.3324/haematol.2015.129924

Cite this

@article{dc99b54f40d94c679eae5672c5c48da2,

title = "Rituximab maintenance therapy in diffuse large B-cell lymphoma: Is XY the most important variable?",

author = "Lunning, {Matthew A.} and Armitage, {James O.}",

year = "2015",

month = jul,

day = "6",

doi = "10.3324/haematol.2015.129924",

language = "English (US)",

volume = "100",

pages = "853--855",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "7",

}

TY - JOUR

T1 - Rituximab maintenance therapy in diffuse large B-cell lymphoma

T2 - Is XY the most important variable?

AU - Lunning, Matthew A.

AU - Armitage, James O.

PY - 2015/7/6

Y1 - 2015/7/6

UR - http://www.scopus.com/inward/record.url?scp=84936069220&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84936069220&partnerID=8YFLogxK

U2 - 10.3324/haematol.2015.129924

DO - 10.3324/haematol.2015.129924

M3 - Editorial

C2 - 26130511

AN - SCOPUS:84936069220

SN - 0390-6078

VL - 100

SP - 853

EP - 855

JO - Haematologica

JF - Haematologica

IS - 7

ER -

Rituximab maintenance therapy in diffuse large B-cell lymphoma: Is XY the most important variable?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this